From: Computational classifiers for predicting the short-term course of Multiple sclerosis
Clinical end-points | Change EDSS | Disability Progression | Relapse free |
---|---|---|---|
MS subtype | 64 (8) < 0.01 | 70 (9) < 0.01 | 54 (17) 0.03 |
Sex | 62 (11) -0.02 | 70 (9) < 0.01 | 67 (21) 0.30 |
Age | 68 (15) 0.22 | 69 (10) -0.01 | 57 (16) 0.03 |
Baseline EDSS | 65 (16) 0.18 | 72 (13) 0.16 | 59 (11) 0.07 |
Baseline MF | 70 (17) 0.28 | 71 (14) 0.16 | 59 (15) 0.09 |
Baseline MSFC | 63 (10) < 0.01 | 67 (12) -0.02 | 58 (6) -0.02 |
Baseline TWT | 63 (12) 0.03 | 71 (11) 0.05 | 57 (5) -0.03 |
Baseline NHPT | 66 (14) 0.16 | 64 (13) -0.06 | 58 (10) 0.03 |
Treatment (DMD) | 63 (11) -0.02 | 70 (10) 0.00 | 57 (8) -0.02 |
CMCT ADM | 64 (8) < 0.01 | 70 (10) < 0.01 | 55 (14) -0.02 |
CMCT FHB | 69 (15) 0.21 | 75 (15) 0.28 | 58 (4) -0.01 |
MEP score | 59 (10) -0.05 | 67 (13) -0.01 | 56 (8.07) -0.04 |
Grouped MEP score | 64 (15) 0.10 | 71 (12) 0.10 | 55 (9) -0.05 |
CMCT Z score | 65 (14) 0.15 | 70 (15) 0.17 | 58 (5) -0.01 |
Abn TMS | 59 (12) 0.01 | 66 (11) < 0.01 | 57 (7) -0.02 |
T1 vol | 63 (10) -0.03 | 70 (9) < 0.01 | 56 (12) 0.01 |
Gad+ vol | 64 (8) < 0.01 | 70 (9) < 0.01 | 58 (5) -0.01 |
GM vol | 63 (11) -0.02 | 69 (10) -0.01 | 61 (17) 0.14 |
WM vol* | 64 (13) 0.06 | 69 (11) -0.02 | 61 (18) 0.16 |